Osteosarcomas of the mandible: Multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, rare cancer network, GETTEC/refcor and sfce

Annals of Oncology

Volumn 24, Issue 3, 2013, Pages 824-831

  Thariat, J ^a   Schouman, T ^b   Brouchet, A ^c   Sarini, J ^d   Miller, R C ^e   Reychler, H ^f   Ray Coquard, I ^g   Italiano, A ^h   Verite, C ^c   Sohawon, S ⁱ   Bompas, E ^j   Dassonville, O ^k   Salas, S ^l   Aldabbagh, K ^m   Maingon, P ⁿ   de la MotteRouge, T ^b   Kurtz, J E ^o   Usseglio, J ^p   Kerbrat, P ^q   Raoul, G ^r   Lotz, J P ^s   Bar Sela, G ^t   Brugieres L ^u   Chaigneau, L ^v   Saada, E ^w   Odin, G ^w   Marcy, P Y ^c   Thyss, A ^a   Julieron, M ^u   more..

^a CENTRE ANTOINE LACASSAGNE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Department of Pathology ^*  (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g CENTRE LÉON BÉRARD   (France)

^h INSTITUT BERGONIÉ   (France)

ⁱ JULES BORDET INSTITUTE   (Belgium)

^j Cancer Center   (France)

^k Institut Universitaire de la Face et du Cou   (France)

^l University Hospital   (France)

^m CENTRE VAL D AURELLE   (France)

ⁿ CENTRE GEORGES FRANÇOIS LECLERC   (France)

^o UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^p DUPUYTREN UNIVERSITY HOSPITAL   (France)

^q RENNES UNIVERSITY HOSPITAL   (France)

^r Cardiology Hospital   (France)

^s HÔPITAL TENON   (France)

^t Division of Medical Oncology   (Italy)

^u INSTITUT GUSTAVE ROUSSY   (France)

^v UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^w UNIVERSITY HOSPITAL OF NICE   (France)

more..

Author keywords

Head and neck; Jaw; Mandible; Osteosarcoma; Prognostic; Treatment

Indexed keywords

ANTHRACYCLINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE;

ADULT; AGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARTILAGE CELL; CLEAR MARGIN; CLINICAL STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; FIBROBLAST; FOLLOW UP; FREE TISSUE GRAFT; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANDIBLE CANCER; MEDICAL SOCIETY; METASTASIS FREE SURVIVAL; OSTEOBLAST; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RETROSPECTIVE STUDY; SURGERY; TUMOR VOLUME;

EID: 84874580869     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds507     Document Type: Article

References (62)

1. van Es RJ, Keus RB, van der Waal I et al.. Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg 1997; 26: 191-197.
2. Clark JL, Unni KK, Dahlin DC et al.. Osteosarcoma of the jaw. Cancer 1983; 51: 2311-2316.
3. Laskar S, Basu A, Muckaden MA et al.. Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients. Head Neck 2008; 30: 1020-1026.
4. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3-13.
5. Smith RB, Apostolakis LW, Karnell LH et al.. National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 2003; 98: 1670-1680.
6. Smeele LE, Snow GB, van der Waal I. Osteosarcoma of the head and neck: meta-analysis of the nonrandomized studies. Laryngoscope 1998; 108: 946.
7. Kassir RR, Rassekh CH, Kinsella JB et al.. Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope 1997; 107: 56-61.
8. Jasnau S, Meyer U, Potratz J et al.. Craniofacial osteosarcoma experience of the cooperative German-Austrian-Swiss Osteosarcoma Study Group. Oral Oncol 2008; 44: 286-294.
9. Patel SG, Meyers P, Huvos AG et al.. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer 2002; 95: 1495-1503.
10. Canadian SoO-HaNSOSG. Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol 2004; 33: 139-144.
11. August M, Magennis P, Dewitt D. Osteogenic sarcoma of the jaws: factors influencing prognosis. Int J Oral Maxillofac Surg 1997; 26: 198-204.
12. Bertoni F, Dallera P, Bacchini P et al.. The Instituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer 1991; 68: 1555-1563.
13. Nissanka EH, Amaratunge EA, Tilakaratne WM. Clinicopathological analysis of osteosarcoma of jaw bones. Oral Dis 2007; 13: 82-87.
14. Fernandes R, Nikitakis NG, Pazoki A et al.. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg 2007; 65: 1286-1291.
15. Oda D, Bavisotto LM, Schmidt RA et al.. Head and neck osteosarcoma at the University of Washington. Head Neck 1997; 19: 513-523.
16. Thariat J, Julieron M, Brouchet A et al. Osteosarcomas of the mandible: are they different from other tumor sites? Crit Rev Oncol Hematol 2012; 82: 280-295.
17. DeLaney TF, Park L, Goldberg SI et al.. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 2005; 61: 492-498.
18. Garrington GE, Scofield HH, Cornyn J et al.. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer 1967; 20: 377-391.
19. Ajura AJ, Lau SH. A retrospective clinicopathological study of 59 osteogenic sarcoma of jaw bone archived in a stomatology unit. Malays J Pathol 2010; 32: 27-34.
20. Slootweg PJ, Muller H. Osteosarcoma of the jaw bones. Analysis of 18 cases. J Maxillofac Surg 1985; 13: 158-166.
21. Doval DC, Kumar RV, Kannan V et al.. Osteosarcoma of the jaw bones. Br J Oral Maxillofac Surg 1997; 35: 357-362.
22. Bennett JH, Thomas G, Evans AW et al.. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 323-332.
23. Park HR, Cabrini RL, Araujo ES et al.. Expression of ezrin and metastatic tumor antigen in osteosarcomas of the jaw. Tumori 2009; 95: 81-86.
24. Ketabchi A, Kalavrezos N, Newman L. Sarcomas of the head and neck: a 10-year retrospective of 25 patients to evaluate treatment modalities, function and survival. Br J Oral Maxillofac Surg 2011; 49: 116-120.
25. Forteza G, Colmenero B, Lopez-Barea F. Osteogenic sarcoma of the maxilla and mandible. Oral Surg Oral Med Oral Pathol 1986; 62: 179-184.
26. Padilla RJ, Murrah VA. The spectrum of gnathic osteosarcoma: caveats for the clinician and the pathologist. Head Neck Pathol 2011; 5: 92-99.
27. Briant TD, Bird R. Osteogenic sarcoma of the mandible. J Otolaryngol 1981; 10: 149-161.
28. Granados-Garcia M, Luna-Ortiz K, Castillo-Oliva HA et al.. Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma. Oral Oncol 2006; 42: 172-176.
29. Gardner GM, Steiniger JR. Family cancer syndrome: a study of the kindred of a man with osteogenic sarcoma of the mandible. Laryngoscope 1990; 100: 1259-1263.
30. Benjamin RS, Patel SR. Pediatric and adult osteosarcoma: comparisons and contrasts in presentation and therapy. Cancer Treat Res 2010; 152: 355-363.
31. Franco Gutierrez V, Llorente Pendas JL, Coca Pelaz A et al.. Radiation-induced sarcomas of the head and neck. J Craniofac Surg 2008; 19: 1287-1291.
32. Sagerman RH, Cassady JR, Tretter P et al.. Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med 1969; 105: 529-535.
33. Arlen M, Higinbotham NL, Huvos AG et al.. Radiation-induced sarcoma of bone. Cancer 1971; 28: 1087-1099.
34. Sim FH, Cupps RE, Dahlin DC et al.. Postradiation sarcoma of bone. J Bone Joint Surg Am 1972; 54: 1479-1489.
35. Frassica FJ, Frassica DA, Wold LE et al.. Postradiation sarcoma of bone. Orthopedics 1993; 16: 105-106, 109.
36. Bielack S, Carrle D, Casali PG. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20(Suppl 4): 137-139.
37. Shao Z, He Y, Wang L et al.. Computed tomography findings in radiation-induced osteosarcoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: e88-e94.
38. Gladdy RA, Qin LX, Moraco N et al.. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol 2010; 28: 2064-2069.
39. Morrison A, Brady J. Mandibular reconstruction using nonvascularized autogenous bone grafting. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 227-231.
40. McHugh JB, Thomas DG, Herman JM et al.. Primary versus radiation-associated craniofacial osteosarcoma: biologic and clinicopathologic comparisons. Cancer 2006; 107: 554-562.
41. Smith J. Radiation-induced sarcoma of bone: clinical and radiographic findings in 43 patients irradiated for soft tissue neoplasms. Clin Radiol 1982; 33: 205-221.
42. Mardinger O, Givol N, Talmi YP et al.. Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 445-451.
43. Ogunlewe MO, Ajayi OF, Adeyemo WL et al.. Osteogenic sarcoma of the jaw bones: a single institution experience over a 21-year period. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 76-81.
44. Demicco EG, Deshpande V, Nielsen GP et al.. Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases. Am J Surg Pathol 2010; 34: 1647-1655.
45. Jawad SN, Abdullah BH. Proliferative, apoptotic and angiogenic potentials in jaws and long bones osteosarcomas: a comparative immunohistochemical study. J Oral Pathol Med 2011; 39: 681-686.
46. Souhami RL, Craft AW, Van der Eijken JW et al.. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350: 911-917.
47. Dahlin D, Unni K. Osteosarcoma Bone Tumors. Springfield, IL: Charles C Thomas 1986; 269-307.
48. Thariat J, Ray-Coquard I, Thyss A et al.. Primary osteosarcomas of the mandible: joint study of the groupe sarcome francais (GSF), rare cancer network and groupe d'Etude des tumeurs de la tete et du cou (GETTEC). J Clin Oncol ASCO annual meeting 2011; 29: (suppl; abstr 10036).
49. deFries HO, Perlin E, Leibel SA. Treatment of osteogenic sarcoma of the mandible. Arch Otolaryngol 1979; 105: 358-359.
50. Guadagnolo BA, Zagars GK, Raymond AK et al.. Osteosarcoma of the jaw/ craniofacial region: outcomes after multimodality treatment. Cancer 2009; 115: 3262-3270.
51. Thiele OC, Freier K, Bacon C et al.. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study. Br J Oral Maxillofac Surg 2008; 46: 533-536.
52. Rosen G, Murphy ML, Huvos AG et al.. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 1976; 37: 1-11.
53. Edmonson JH, Green SJ, Ivins JC et al.. A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 1984; 2: 152-156.
54. Smeele LE, van der Wal JE, van Diest PJ et al.. Radical surgical treatment in craniofacial osteosarcoma gives excellent survival. A retrospective cohort study of 14 patients. Eur J Cancer B Oral Oncol 1994; 30B: 374-376.
55. Smeele LE, Kostense PJ, van der Waal I et al.. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 1997; 15: 363-367.
56. Guadagnolo BA, Zagars GK, Ballo MT et al.. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 760-765.
57. Lewis IJ, Nooij MA, Whelan J et al.. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007; 99: 112-128.
58. Ha PK, Eisele DW, Frassica FJ et al.. Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope 1999; 109: 964-969.
59. Pellitteri PK, Ferlito A, Bradley PJ et al.. Management of sarcomas of the head and neck in adults. Oral Oncol 2003; 39: 2-12.
60. Delaney TF, Kepka L, Goldberg SI et al.. Radiation therapy for control of softtissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys 2007; 67: 1460-1469.
61. Gomez AC, Youmans RD, Chambers RG. Osteogenic sarcoma of the mandible. A method of treatment. Am J Surg 1960; 100: 613-616.
62. Salas S, de Pinieux G, Gomez-Brouchet A et al.. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma. Virchows Arch 2009; 454: 81-87.